JDRR — F3 Platform Biologics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual balance sheet for F3 Platform Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0.091 | 0.095 | 0.302 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0.009 | 0.017 | 0.05 |
| Total Current Assets | 0.1 | 0.112 | 0.353 |
| Long Term Notes Receivable | |||
| Total Assets | 0.1 | 0.142 | 0.353 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Current Liabilities | 2.72 | 3.17 | 2.89 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 6.32 | 6.27 | 7.21 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -6.22 | -6.13 | -6.86 |
| Total Liabilities & Shareholders' Equity | 0.1 | 0.142 | 0.353 |
| Total Common Shares Outstanding |